New Agents and Therapeutic Strategies in β-Thalassemia

Get the latest insights on novel therapeutic and curative strategies for β-thalassemia with an expert commentary plus slides and an on-demand Webcast from a live CCO Webinar at ASH 2020.
Janet L. Kwiatkowski, MD, MSCE

ClinicalThought

Gain insights on recent developments in the care of patients with β-thalassemia along with ongoing clinical issues and emerging therapies to address them.

Janet L. Kwiatkowski, MD, MSCE Released: November 12, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Bristol-Myers Squibb

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue